Proposed CMS Rule Change Would Restrict Access to Anticancer Medications
Of the 143 brand name protected class drugs that exist, more than half are antineoplastics.
News
Latest News
Surveillance Imaging Not Linked to Better Outcomes in Follicular Lymphoma, Further Evidence Shows
Another study showed that surveillance imaging for patients with follicular lymphoma did not improve survival outcomes after first relapse.
Frailty Predicts Higher In-Hospital Mortality After Radical Cystectomy
Frail patients are more likely than non-frail patients to experience adverse perioperative outcomes after radical cystectomy, a study found.
Risk Factors for CVD More Common in Postmenopausal Women Who Survived Breast Cancer
Researchers compared the development of specific CVD risk factors in postmenopausal women who survived breast cancer and women without history of breast cancer.
Depression at Time of Diagnosis May Worsen Survival in Blood Cancers
Risk for death higher even with depression remission versus never experiencing depression.
RCC Ablation Technique Influences Survival Time
One type thermal ablation appeared superior for cT1 a renal cell carcinoma patients.
Facilitating CAR-T Cell Therapy in Solid Tumors Through “Vaccine Boosting”
Bispecific CAR-T cells were engineered to target both tumor antigen and vaccine-specific antigens to boost CAR-T function through an amphiphilic vaccine.
The Utility of Endoscopic Techniques in the Diagnosis of Gastric Lymphoma
A case report suggests that endoscopic techniques may have utility in the diagnosis of the gastric involvement that can occur in follicular lymphoma.
Determining Risk Factors for Recurrence of Primary Localized Cutaneous Melanoma
Researchers sought to determine the risk of disease recurrence in patients with localized melanoma at high risk of disease metastasis.
Many Perceive Lack of Choice in Receipt of RAI for Thyroid Cancer
Thyroid cancer patients who perceive no choice about radioactive iodine report lower decision satisfaction.
Post-Op Radiation Safely Eliminated in Node-Negative Neck HNSCC
Elimination of radiation therapy did not alter quality-of-life outcomes.
Likelihood of LVDD is Predictive of Carfilzomib-Induced Cardiovascular AEs in R/R Multiple Myeloma
In this retrospective study, researchers investigated whether assessing left ventricular diastolic function in patients receiving carfilzomib for relapsed or refractory multiple myeloma improved risk of cardiovascular adverse events.
Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL
Inferior survival for patients with chronic lymphocytic leukemia who progress with lymphadenopathy.
State-Level Variation Noted in Economic Burden of Cancer
Lost earnings of $94.4 billion reported in the United States in 2015.
Zejula Gets Priority Review for Late Stage Ovarian Cancer Indication
The sNDA is supported by data from the multicenter phase 2 QUADRA trial that evaluated the safety and activity of Zejula in 463 patients.
Want to read more?
Please login or register first to view this content.
Next post in ASCO 2019 Breast Cancer In Depth
